Liaoning Cheng Da Co Ltd
SSE:600739
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (1.9), the stock would be worth ¥11.34 (2% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.9 | ¥11.62 |
0%
|
| 3-Year Average | 1.9 | ¥11.34 |
-2%
|
| 5-Year Average | 1.9 | ¥11.32 |
-3%
|
| Industry Average | 1.6 | ¥9.81 |
-16%
|
| Country Average | 3.3 | ¥20.16 |
+74%
|
Forward EV/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
L
|
Liaoning Cheng Da Co Ltd
SSE:600739
|
17.8B CNY | 1.9 | 20.6 | |
| US |
|
Genuine Parts Co
NYSE:GPC
|
15B USD | 0.8 | 249.1 | |
| BE |
|
D'Ieteren Group NV
XBRU:DIE
|
9.3B EUR | 1.3 | 21.9 | |
| US |
|
Pool Corp
NASDAQ:POOL
|
8.5B USD | 1.8 | 21.1 | |
| US |
|
LKQ Corp
NASDAQ:LKQ
|
8.1B USD | 0.8 | 13.3 | |
| ZA |
C
|
CA Sales Holdings Ltd
JSE:CAA
|
7B ZAR | 0.5 | 11 | |
| CN |
|
Wuchan Zhongda Group Co Ltd
SSE:600704
|
26.8B CNY | 0.1 | 7.2 | |
| UK |
|
Inchcape PLC
LSE:INCH
|
2.9B GBP | 0.4 | 10.6 | |
| CN |
|
Zhejiang Orient Financial Holdings Group Co Ltd
SSE:600120
|
19.7B CNY | 2.2 | 14.9 | |
| PL |
I
|
Inter Cars SA
WSE:CAR
|
10.3B PLN | 0.6 | 13.7 | |
| HK |
C
|
China Tobacco International HK Co Ltd
HKEX:6055
|
21B HKD | 1.3 | 21.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.7 |
| Median | 3.3 |
| 70th Percentile | 6.2 |
| Max | 5 034 353.9 |
Other Multiples
Liaoning Cheng Da Co Ltd
Glance View
Liaoning Cheng Da Co Ltd stands as a significant player in the landscape of Chinese conglomerates, weaving a diverse portfolio that strategically aligns with the economic growth patterns of the region. Founded in the bustling province of Liaoning, the company epitomizes a model of diversified investment, underpinning its operations with a well-considered spread across various sectors. Initially, it carved a niche in the trading business, leveraging the abundant natural resources and industrial outputs of its home province to build a steady stream of revenue. This foundation allowed Cheng Da to expand into pharmaceuticals, real estate, and financial investments, each segment contributing distinctively to the company’s overall robustness. Cheng Da’s pharmaceutical business has emerged as a cornerstone, thriving amidst the rising demand for healthcare products in China. This arm of the company is particularly adept in leveraging advanced research methodologies combined with traditional Chinese medicine, thus creating a distinctive edge in both domestic and international markets. Meanwhile, its real estate ventures capably ride the wave of urbanization in China, focusing on premium residential and commercial properties, enhancing the urban landscape while adding to its financial metrics. By sitting at the crossroads of critical sectoral developments and maintaining a keen eye on expansive opportunities, Liaoning Cheng Da Co Ltd astutely navigates the intricate dance of market dynamics, thus cementing its place as a formidable entity in the economic engine of China.